Abstract
The treatment of patients suffering from idiopathic Parkinson's disease has become more and more complex. From its beginning the treatment has to be tailored to the needs of each patient. Not only the individual symptomatology and its course have to be taken into consideration, but also the short- and longtime reaction to treatment.
Publication types
-
Comparative Study
-
English Abstract
-
Review
MeSH terms
-
Adult
-
Aged
-
Antidepressive Agents / therapeutic use
-
Antiparkinson Agents / administration & dosage
-
Antiparkinson Agents / adverse effects
-
Antiparkinson Agents / therapeutic use
-
Antipsychotic Agents / therapeutic use
-
Benserazide / administration & dosage
-
Benserazide / adverse effects
-
Benserazide / therapeutic use
-
Cholinesterase Inhibitors / therapeutic use
-
Clozapine / therapeutic use
-
Dementia / drug therapy
-
Dementia / etiology
-
Depression / drug therapy
-
Depression / etiology
-
Diagnosis, Differential
-
Dopamine Agents / administration & dosage
-
Dopamine Agents / adverse effects
-
Dopamine Agents / therapeutic use
-
Dopamine Agonists / administration & dosage
-
Dopamine Agonists / adverse effects
-
Dopamine Agonists / therapeutic use
-
Drug Combinations
-
Humans
-
Levodopa / administration & dosage
-
Levodopa / adverse effects
-
Levodopa / therapeutic use
-
Parkinson Disease / complications
-
Parkinson Disease / diagnosis
-
Parkinson Disease / drug therapy
-
Parkinson Disease / therapy*
-
Quality of Life
-
Sleep Wake Disorders / etiology
-
Sleep Wake Disorders / therapy
-
Time Factors
Substances
-
Antidepressive Agents
-
Antiparkinson Agents
-
Antipsychotic Agents
-
Cholinesterase Inhibitors
-
Dopamine Agents
-
Dopamine Agonists
-
Drug Combinations
-
benserazide, levodopa drug combination
-
Levodopa
-
Benserazide
-
Clozapine